LPCN

LIPOCINE INC NEW

LPCN·53630X203·US·Common Stock·Healthcare - Biotechnology-13D/G

LPCN (LIPOCINE INC NEW) is held by 22 institutional investors as of Q2 2026. Largest holders: VANGUARD CAPITAL MANAGEMENT LLC ($590,907), JANE STREET GROUP, LLC ($243,781), BlackRock, Inc. ($228,536). Net institutional sentiment: Bullish.

22
Holders
$2.3M
Total Value
75% (20)
Consensus
15 buying - 5 selling
13F: Insider & Congress: Updated regularly
LPCN

Smart Money Verdict

View all
Loading verdict
Held by 22 funds

Who's Trading

Source dates: Price Aug 28, 2026 · Insiders none · Activists Aug 14, 2026 · Congress none

ActivistSMSquadron Master Fund LP9.8%Aug 14, 2026
ActivistSMSquadron Master Fund LP6.2%May 15, 2026

Top Holders

Checking access…
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
230,823(+15.0%)$590,9070.0%-71.91%
19
Increased
95,227(+375.5%)$243,7810.0%-40.06%
25
Unchanged
89,272$228,5360.0%-53.06%
0
Increased
84,887(+151.5%)$217,3110.0%-56.03%
37
Increased
81,221(+179.2%)$207,9260.0%-53.85%
25
Increased
74,477(+18.0%)$190,7610.0%-85.58%
18
Increased
69,209(+79.8%)$177,1750.0%-52.14%
35
Increased
54,539(+68.3%)$139,6200.0%-64.42%
22
Increased
36,775(+92.3%)$94,1440.0%-55.46%
23
Increased
25,376(+1.9%)$64,9630.0%-41.39%
15
Unchanged
22,407$57,3620.0%-42.51%
0
Increased
15,942(+22.2%)$40,8120.0%-70.17%
17
Increased
9,827(+4.4%)$25,1570.0%-73.69%
14
Increased
3,596(+2.9%)$9,2060.0%-59.79%
12
Unchanged
2,706$6,9270.0%-74.47%
0
Unchanged
1,691$4,3290.0%-74.47%
0
Unchanged
574$1,4690.0%-72.61%
0
Increased
238(+66.4%)$6090.0%-43.59%
11
Unchanged
132$3380.0%-52.00%
0
New
29,238$740.0%-16.02%
15

Showing 1-20 of 27

1 / 2
LPCNLPCNLIPOCINE INC NEW

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used